Clinical Trial Update: Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project

View source ↗

Summary

A pregnancy exposure registry studying safety of ustekinumab (Stelara) and guselkumab (Tremfya) during pregnancy in autoimmune diseases; the study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Psoriasis
• Psoriatic Arthritis

Drugs mentioned

• Stelara (ustekinumab)
• TREMFYA (guselkumab)

Snippet

Sponsor: University of California, San Diego | Conditions: Psoriasis, Pregnancy | Status: RECRUITING